Publications
Shepherd JD, Shore T, Reece DE, et al. Cyclosporine/Methylprednisone Prophylaxis for Acute Graft-Vs-Host Disease. Bone Marrow Transplantation in 1988; 3:553-558
Shore T, Eisenhauer E, Quirt I, Belanger K, Lohmann R, Silver H, Wielgosz G. A Phase II Study of DuP 937 (Teloxantrone) in Metastatic Malignant Melanoma: A Study of the National Cancer Institute of Canada Clinical Trials Group (NCIC CTG). Short Report - Annals of Oncology 1993; 4:695-96
Couban Stephen, Simpson David R., Barnett Michael J, Bredeson Christopher, Hubesch Lothar, Howson Jan Kang, Shore Tsiporah B., Walker Irwin R, Browett Peter, Messner Hans A., Panzarella Tony, Lipton Jeffrey H., for the Canadian Bone Marrow Transplant Group: A randomized multicenter ceomparison of bone marrow and peripheral blood in recipients of matched sibling allogeneic transplants for myeloid malignancies. Blood 2002 100: 1525 1531.
ShoreT, Harpel J, Schuster MW, Roboz GJ, Leonard JP, Coleman M, Feldman EJ, Silver RT. A Study of a Reduced-Intensity Conditioning Regimen Followed by Allogeneic Stem Cell Transplantation for Patients with Hematologic Malignancies Using Campath-1H as Part of a Graft-versus-Host Disease Strategy. Biol Blood Marrow Transplant. 2006 Aug;12(8):868-75.
Shore T. Stem Cell Transplantation for Myelodysplastic Syndromes: The Lure of a Cure. Current Hematologic Malignancy Reports. 2007. Vol. 2, No. 7:3-8.
